Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug;17(8):e1162-e1169.
doi: 10.1200/OP.20.00683. Epub 2021 Feb 23.

Implementation of the Quality Oncology Practice Initiative Program in Spain: First Results and Implications

Affiliations

Implementation of the Quality Oncology Practice Initiative Program in Spain: First Results and Implications

Carlos Camps et al. JCO Oncol Pract. 2021 Aug.

Abstract

Purpose: Measuring and tracking quality of care is highly relevant in today's health care. The Quality Oncology Practice Initiative (QOPI) program is a referral for evaluating oncology practices worldwide. Excellence and Quality in Oncology Foundation, a collaboration of oncology experts from major Spanish hospitals involved in cancer treatment, reached an agreement with QOPI to include Spanish hospitals in this program.

Methods: We analyzed the results of the QOPI Core module measures from 19 Spanish hospitals over nine rounds (from fall 2015 to fall 2019).

Results: Of the 19 hospitals, 15 completed more than one round; none participated in all nine (two hospitals participated in eight rounds). The highest scores were for pathology report confirming malignancy, documenting a plan of care for moderate or severe pain and chemotherapy dose, and chemotherapy administered to patients with metastatic solid tumor with performance status undocumented. Measures regarding a summary of chemotherapy treatment, tobacco use cessation counseling, and assessment of patient emotional well-being were among the lowest scored measures. Six of the 15 practices that participated repeatedly achieved a better score in their last round compared with their first. Overall, scores of Spanish hospitals improved from 67.79% in fall 2015 to 68.91% in fall 2019.

Conclusion: To our knowledge, this is the first study to evaluate QOPI scores in Spain. There was high variability in scores, with quality of care improving with repeated participation in some hospitals, but worsening in others. Excellence and Quality in Oncology Foundation will support practices to increase their participation to improve oncology care and implement strategies that address the areas for improvement.

PubMed Disclaimer

Conflict of interest statement

Carlos CampsHonoraria: BayerConsulting or Advisory Role: AstraZenecaResearch Funding: Boehringer IngelheimTravel, Accommodations, Expenses: MSD Oncology, AstraZeneca, Bristol-Myers Squibb Rafael LópezStock and Other Ownership Interests: NasasbiotechConsulting or Advisory Role: Roche,Bayer, MSD, Bristol-Myers Squibb, Janssen, LillySpeakers' Bureau: Novartis, Roche, Lilly, Pfizer, RoviResearch Funding: Roche, Lilly, MerckTravel, Accommodations, Expenses: Roche, Pierre Fabre, Tesaro, Pfizer Antonio AntónConsulting or Advisory Role: Bayer Alfredo CarratoConsulting or Advisory Role: Roche, Bayer, Merck, Servier, MSD Oncology, BaxterTravel, Accommodations, Expenses: Merck, Celgene, Bristol-Myers Squibb Juan Jesús CruzConsulting or Advisory Role: MSD Oncology, Bristol-Myers Squibb, MerckSpeakers' Bureau: MSD Oncology, Bristol-Myers Squibb, Merck, Roche, Janssen Oncology, AstraZenecaTravel, Accommodations, Expenses: MSD Oncology Jesús García-FoncillasHonoraria: Merck KGaA, Bayer, Sanofi, SERVIERConsulting or Advisory Role: BayerSpeakers' Bureau: BayerTravel, Accommodations, Expenses: Janssen Pere GascónConsulting or Advisory Role: Merck SharpandDohmeSpeakers' Bureau: AMGEN, Sandoz Vicente GuillemHonoraria: Astellas Pharma, Roche, Janssen, Bristol-Myers SquibbConsulting or Advisory Role: Astellas Pharma, BayerResearch Funding: Roche, NovartisTravel, Accommodations, Expenses: Lilly, MSD Oncology, RocheNo other potential conflicts of interest were reported.

Publication types

LinkOut - more resources